OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
LYKI57

Lykis Ltd

Food Retail & DistributionVerified

Lykis operates with a debt-to-equity ratio of 2.61, indicating a capital structure that is significantly leveraged, with long-term debt accounting for a large portion of its total liabilities. The company's liquidity position is moderate, as evidenced by a current ratio of 1.04, suggesting that it has just enough current assets to cover its current liabilities. However, the company's operating cash flow is negative at -321.66 million INR, which raises concerns about its ability to fund operations from core business activities. Profitability metrics show that Lykis has a return on equity (ROE) of 15.87%, which is relatively strong, but its return on assets (ROA) is only 3.41%, indicating that the company is not efficiently utilizing its assets to generate returns. The gross profit margin is 12.02% (472.20 million INR gross profit on 3,927.46 million INR revenue), and the operating margin is 2.15% (84.34 million INR operating income on 3,927.46 million INR revenue), both of which are below the industry median for Food Retail & Distribution. Lykis generates revenue from a diverse set of segments, including personal care, FMCG, and commodity products. The company's revenue is not heavily concentrated in any single geographic region, but its operations are primarily based in India. The company's product portfolio includes a wide range of brands, such as Lykis, Rox, H&H, and others, which are distributed across various consumer segments. The company's growth trajectory is mixed. While it has a free cash flow of 77.58 million INR, indicating some capacity to reinvest or return capital to shareholders, its capital expenditure is minimal at -476,000 INR, suggesting limited investment in new projects or expansion. The outlook for the current fiscal year is uncertain, with no clear direction provided, and the next fiscal year's outlook is similarly ambiguous. Risk factors for Lykis include its high debt load and negative operating cash flow, which could lead to liquidity constraints. The company's dilution risk is currently low, but the presence of long-term debt and the potential for future financing needs could increase this risk. The company's financial structure and cash flow dynamics suggest that it may need to seek additional financing in the near term, which could lead to dilution or increased debt servicing costs. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company continues to focus on its core export business and private labeling solutions. There are no significant new product launches or strategic acquisitions reported in the latest filings, and the company's management has not indicated any major shifts in direction.

30-day price · LYKI-3.18 (-6.7%)
Low$41.58High$54.79Close$43.94As of15 May, 00:00 UTC
Profile
CompanyLykis Ltd
TickerLYKI.BO
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Lykis Limited exports fast-moving consumer goods (FMCG), cosmetics, and other products, offering manufacturing support and end-to-end private labeling solutions for a diverse range of FMCG, cosmetics, and raw material/finished product goods.

Classification. Lykis is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry with a confidence level of 0.92.

Lykis operates with a debt-to-equity ratio of 2.61, indicating a capital structure that is significantly leveraged, with long-term debt accounting for a large portion of its total liabilities. The company's liquidity position is moderate, as evidenced by a current ratio of 1.04, suggesting that it has just enough current assets to cover its current liabilities. However, the company's operating cash flow is negative at -321.66 million INR, which raises concerns about its ability to fund operations from core business activities. Profitability metrics show that Lykis has a return on equity (ROE) of 15.87%, which is relatively strong, but its return on assets (ROA) is only 3.41%, indicating that the company is not efficiently utilizing its assets to generate returns. The gross profit margin is 12.02% (472.20 million INR gross profit on 3,927.46 million INR revenue), and the operating margin is 2.15% (84.34 million INR operating income on 3,927.46 million INR revenue), both of which are below the industry median for Food Retail & Distribution. Lykis generates revenue from a diverse set of segments, including personal care, FMCG, and commodity products. The company's revenue is not heavily concentrated in any single geographic region, but its operations are primarily based in India. The company's product portfolio includes a wide range of brands, such as Lykis, Rox, H&H, and others, which are distributed across various consumer segments. The company's growth trajectory is mixed. While it has a free cash flow of 77.58 million INR, indicating some capacity to reinvest or return capital to shareholders, its capital expenditure is minimal at -476,000 INR, suggesting limited investment in new projects or expansion. The outlook for the current fiscal year is uncertain, with no clear direction provided, and the next fiscal year's outlook is similarly ambiguous. Risk factors for Lykis include its high debt load and negative operating cash flow, which could lead to liquidity constraints. The company's dilution risk is currently low, but the presence of long-term debt and the potential for future financing needs could increase this risk. The company's financial structure and cash flow dynamics suggest that it may need to seek additional financing in the near term, which could lead to dilution or increased debt servicing costs. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company continues to focus on its core export business and private labeling solutions. There are no significant new product launches or strategic acquisitions reported in the latest filings, and the company's management has not indicated any major shifts in direction.
Key takeaways
  • Lykis has a strong ROE of 15.87% but a weak ROA of 3.41%, indicating inefficiencies in asset utilization.
  • The company's debt-to-equity ratio of 2.61 suggests a high level of leverage, which increases financial risk.
  • Lykis has a negative operating cash flow of -321.66 million INR, which could impact its ability to fund operations.
  • The company's free cash flow of 77.58 million INR provides some flexibility for reinvestment or shareholder returns.
  • Lykis operates in a diverse range of segments, including personal care, FMCG, and commodity products, with no single geographic concentration.
  • The company's capital expenditure is minimal, indicating limited investment in growth or expansion.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$3.93B
Gross profit$472.2M
Operating income$84.3M
Net income$64.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$321.7M
CapEx-$476.0k
Free cash flow$77.6M
Total assets$1.90B
Total liabilities$1.49B
Total equity$408.0M
Cash & equivalents$72.5M
Long-term debt$1.07B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$408.0M
Net cash-$993.4M
Current ratio1.0
Debt/Equity2.6
ROA3.4%
ROE15.9%
Cash conversion-5.0%
CapEx/Revenue-0.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
MetricLYKIActivity
Op margin2.1%2.8% medp25 0.9% · p75 5.9%below median
Net margin1.6%1.8% medp25 0.3% · p75 3.6%below median
Gross margin12.0%24.1% medp25 13.8% · p75 31.4%bottom quartile
CapEx / revenue-0.0%-2.0% medp25 -3.8% · p75 -1.0%top quartile
Debt / equity261.0%56.0% medp25 14.0% · p75 113.8%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 03:13 UTC#9a8c0d75
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 03:14 UTCJob: bb5b4b06